Whether maternal tolerance of the fetus reflects selectively antigen-specific immune regulation or a global, non-specific dampening of maternal immunity was posed by the source literature (Breckler et al. 2008; Rowe et al. 2012; Barton et al. 2016) and has since been substantially clarified. In mice, fetal antigen drives antigen-specific programs - expansion and long-term regulatory memory of fetal-antigen-specific FOXP3+ regulatory T cells and selective dysfunction of fetal-specific CD8 T cells - while systemic immune competence is largely preserved, with antigen-independent molecular circuits operating in parallel. In humans, fetus-specific T-cell hyporesponsiveness has now been demonstrated with paired fetus-matched versus unrelated-donor controls, but only at bulk functional resolution, late in gestation, and cross-sectionally. The open core that remains is the antigen-level mechanistic account in humans: the clonal dynamics and fates of fetal-antigen-specific maternal T cells across gestation and successive pregnancies, and the integration of antigen-specific and antigen-independent programs that restrains anti-fetal reactivity while preserving host defense, including currently unexplained exceptions such as grand multiparous women (women of very high parity) with heightened fetus-specific responses and cytotoxic fetus-specific CD8 cells in the healthy decidua.

Background

Successful mammalian pregnancy requires the mother's immune system to coexist with a genetically foreign tissue. The fetus and placenta express paternally inherited alloantigens - molecules, chiefly proteins bound to or derived from the major histocompatibility complex (MHC), that differ from the mother's own - yet destructive maternal immune responses normally do not occur. The classical debate asked whether this reflects antigen-specific tolerance (selective silencing of lymphocytes that recognize fetal or paternal antigens) or a global, non-specific dampening of maternal immunity. The global view predicted generalized immunosuppression during pregnancy; instead, systematic measurements found no quantitative loss of systemic immune responsiveness in healthy pregnant women (Lashley et al. 2010), although antigen-independent modulation does exist: cytotoxic T lymphocyte reactivity in pregnant mares drops against the breeding stallion and against completely unrelated third-party horses alike, including in MHC-compatible pregnancies (Noronha and Antczak 2012).

A first tier of evidence established the antigen-specific arm. CD4+ regulatory T cells (Tregs) - suppressive T lymphocytes whose differentiation and function depend on the transcription factor FOXP3 - expand during pregnancy, and their expansion is mandatory: even transient partial ablation of FOXP3+ cells in mice breaks tolerance to fetal antigen and triggers fetal resorption, while the same expansion creates naturally occurring holes in host defense that increase susceptibility to prenatal bacterial pathogens such as Listeria (Rowe et al. 2011). The antigen specificity of this response was resolved with tetramer-based enrichment - staining rare antigen-specific T cells using multimeric complexes of MHC molecules loaded with the antigenic peptide and enriching them magnetically so that rare endogenous clones can be counted - showing that pregnancy selectively accumulates maternal FOXP3+ CD4 T cells with fetal specificity, that these cells persist at elevated frequency after delivery, and that they re-expand rapidly during subsequent pregnancy, that is, pregnancy imprints regulatory memory (Rowe et al. 2012). Independently, peripherally induced (extrathymic) Tregs specific for a model paternal antigen were shown to be generated during pregnancy through an evolutionarily conserved enhancer (CNS1) in the Foxp3 locus, and females lacking this mechanism show increased fetal resorption when mated with allogeneic males (Samstein et al. 2012).

A second tier established the fate of fetal-antigen-specific effector T cells. Fetal antigen exposure primes maternal CD8 T cells, but these cells do not differentiate into canonical cytotoxic memory: they persist long term with a PD-1+ phenotype (programmed death 1, an inhibitory receptor marking exhausted or dysfunctional T cells) and fail to expand or produce cytokines robustly upon re-encounter in a second pregnancy, while skin grafts carrying the same antigen are rejected faster - a selective, context-dependent effector dysfunction rather than global unresponsiveness (Barton et al. 2016). Molecularly, maternal CD8 T-cell hypofunction splits into NFAT-dependent circuit elements (NFAT, nuclear factor of activated T cells, a transcription factor family) that require fetal antigen and NFAT-independent elements that do not, indicating that antigen-specific and antigen-independent programs are interwoven even within one cell type (Lewis et al. 2022). Notably, the same pregnancies that tolerize T cells also sensitize humoral immunity: mice simultaneously generate fetus-specific T-cell tolerance and anti-fetal antibodies, and the antibodies override the T-cell tolerance for antigen-matched organ grafts (Suah et al. 2021), a duality long known clinically as pregnancy-induced anti-HLA (human leukocyte antigen, the human version of MHC) sensitization (Porrett 2018).

In humans, the picture is coarser. Fetus-specific suppressive capacity is selectively redistributed from maternal peripheral blood to the decidua - the modified uterine lining at the implantation site, where maternal immune cells directly contact fetal trophoblast (the outer, maternal-facing cell layer of the placenta) - while regulation of third-party responses is retained in blood (Tilburgs et al. 2008). HY-specific T cells (specific for male-specific minor histocompatibility antigens, that is, proteins encoded on the Y chromosome and foreign to mothers carrying male fetuses) can be detected in third-trimester decidua in a highly differentiated state (Powell et al. 2017), and fetus- and virus-specific decidual CD8 tissue-resident memory cells show similar inhibitory and cytotoxic features, indicating that not all fetus-specific CD8 responses are suppressed at the maternal-fetal interface (Mahajan et al. 2023). Single-cell profiling of term decidua shows locally expanding regulatory T cells of predominantly thymic origin under chronic antigenic stimulation, but fetal specificity cannot yet be attributed at the clonal level (Verleng et al. 2026). Most directly, a 2025 study stimulated maternal peripheral blood mononuclear cells with fetus-matched versus fetus-unmatched (third-party) cord-blood dendritic cells and found significantly lower interferon-gamma (IFN-gamma, an inflammatory T-cell cytokine) and broader T-helper 1 and T-helper 2 (Th1/Th2) cytokine responses to the mother's own fetus, confirming fetus-specific T-cell hyporesponsiveness in humans - but at bulk resolution, near delivery, in modest cohorts, and with a striking exception: a subset of grand multiparous women - women with very high parity, conventionally five or more prior births - showed heightened fetus-matched responses yet delivered at term (Morgan et al. 2025). Reviews now frame antigen-specific Treg-mediated tolerance and non-specific homeostatic regulation (for example by decidual macrophages) as complementary layers rather than alternatives (Kieffer et al. 2019; Gomez-Lopez et al. 2026).

What remains missing is precisely a mechanistic account at antigen level in humans: no longitudinal, tetramer- or T-cell-receptor (TCR) clonal-resolution tracking of fetal-antigen-specific maternal T cells across gestation and parities exists, and how antigen-specific and antigen-independent programs are integrated so that anti-fetal reactivity is selectively restrained while pathogen defense is preserved - including the unexplained exceptions - is not settled.

Problem Statement

Supply the antigen-level mechanistic account of selective maternal tolerance to fetal alloantigens that the source literature posed and later work has not yet delivered, in two linked components that jointly answer how the maternal immune system discriminates fetal antigen from pathogen while preserving host defense. (1) Clonal dynamics: determine, in human pregnancy, the frequencies, phenotypes, expansion kinetics, and fates of fetal-antigen-specific maternal T cells - FOXP3+ CD4 regulatory T cells, conventional CD4 T cells, and CD8 T cells - at antigen-level resolution (for example by validated MHC-peptide tetramer enrichment, or single-cell T-cell receptor clonotype assignment validated against fetal and paternal genotypes); where the corresponding human antigen-level measurements are not yet available, the account required is the best-supported one for these dynamics together with its evidential basis, distinguishing what is measured directly in humans from what is inferred from mouse or bulk human data. An informative study would ideally track these cells across gestational time points, delivery, and postpartum, and across successive pregnancies, and would compare responses to the mother's own fetal/paternal antigens with responses to unrelated third-party donor antigens so that antigen-specific and antigen-independent effects are separated; such designs are illustrative routes and expected evidential strengths for the question, not mandatory completeness conditions. Mouse-model work may inform the mechanistic parts that cannot be manipulated in humans; the clonal-dynamics question itself concerns human pregnancy. (2) Mechanistic integration: establish which cellular and molecular programs produce the observed selectivity (fetal-antigen-driven Treg expansion and regulatory memory; selective effector-cell dysfunction; local decidual versus systemic redistribution) and how these interact with antigen-independent mechanisms (hormonal, cytokine-driven, and antigen-independent transcriptional circuits), such that responses to fetal and paternal alloantigens are selectively restrained while immune competence against pathogens is preserved. A complete answer must be consistent with the documented boundary observations: the prenatal-infection susceptibility created by Treg expansion, the coexistence of humoral anti-fetal sensitization with T-cell tolerance, cytotoxic fetus-specific CD8 cells in the healthy decidua, and grand multiparous women (women of very high parity) who sustain uncomplicated pregnancies despite heightened fetus-specific T-cell responses.

References

  1. Breckler LA, Hale J, Taylor A, Dunstan JA, Thornton CA, Prescott SL (2008) Pregnancy IFN-gamma responses to foetal alloantigens are altered by maternal allergy and gravidity status. Allergy 63(11):1473-1480. DOI 10.1111/j.1398-9995.2008.01718.x, https://doi.org/10.1111/j.1398-9995.2008.01718.x
  2. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS (2011) Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host & Microbe 10(1):54-64. DOI 10.1016/j.chom.2011.06.005, https://doi.org/10.1016/j.chom.2011.06.005
  3. Rowe JH, Ertelt JM, Xin L, Way SS (2012) Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490(7418):102-106. DOI 10.1038/nature11462, https://doi.org/10.1038/nature11462
  4. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150(1):29-38. DOI 10.1016/j.cell.2012.05.031, https://doi.org/10.1016/j.cell.2012.05.031
  5. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH (2008) Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. Journal of Immunology 180(8):5737-5745. DOI 10.4049/jimmunol.180.8.5737, https://doi.org/10.4049/jimmunol.180.8.5737
  6. Lashley LEE, Van Der Hoorn MP, Van Der Mast BJ, Tilburgs T, Van Der Lee N, Van Beelen E, Roelen DL, Claas FHJ, Scherjon SA (2010) No quantitative changes in the systemic immune response during pregnancy despite changes in cytokine production and composition of leucocytes. Journal of Reproductive Immunology 86(1):45. DOI 10.1016/j.jri.2010.06.089, https://doi.org/10.1016/j.jri.2010.06.089
  7. Noronha LE, Antczak DF (2012) Modulation of T-cell reactivity during equine pregnancy is antigen independent. American Journal of Reproductive Immunology 68(2):107-115. DOI 10.1111/j.1600-0897.2012.01154.x, https://doi.org/10.1111/j.1600-0897.2012.01154.x
  8. Barton BM, Xu R, Wherry EJ, Porrett PM (2017, online 2016) Pregnancy promotes tolerance to future offspring by programming selective dysfunction in long-lived maternal T cells. Journal of Leukocyte Biology 101(4):975-987. DOI 10.1189/jlb.1A0316-135R, https://doi.org/10.1189/jlb.1A0316-135R
  9. Suah AN, Tran DV, Khiew SH, Andrade MS, Pollard JM, Jain D, Young JS, Yin D, Chalasani G, Alegre ML, Chong AS (2021) Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. Journal of Clinical Investigation 131(1):e140715. DOI 10.1172/jci140715, https://doi.org/10.1172/jci140715
  10. Lewis EL, Xu R, Beltra JC, Ngiow SF, Cohen J, Telange R, Crane A, Sawinski D, Wherry EJ, Porrett PM (2022) NFAT-dependent and -independent exhaustion circuits program maternal CD8 T cell hypofunction in pregnancy. Journal of Experimental Medicine 219(1):e20201599. DOI 10.1084/jem.20201599, https://doi.org/10.1084/jem.20201599
  11. Mahajan S, Alexander A, Koenig Z, Saba N, Prasanphanich N, Hildeman DA, Chougnet CA, DeFranco E, Andorf S, Tilburgs T (2023) Antigen-specific decidual CD8+ T cells include distinct effector memory and tissue-resident memory cells. JCI Insight 8(17):e171806. DOI 10.1172/jci.insight.171806, https://doi.org/10.1172/jci.insight.171806
  12. Morgan JC, Hynes GE, Pollard JM, Andrade MS, Jeong JC, Chong AS (2025) Hyporesponsive fetus-specific T cell responses in multiparous human pregnancy. Frontiers in Immunology 16:1634430. DOI 10.3389/fimmu.2025.1634430, https://doi.org/10.3389/fimmu.2025.1634430
  13. Thiele K, Urbschat C, Riquelme JIA, Ahrendt LS, Wohrle R, Schepanski S, Eckert JJ, Becht E, Qi M, Alawi M, Becker M, Gagliani N, Mittrucker HW, Diemert A, Arck PC (2025) Pregnancy-acquired memory CD4(+) regulatory T cells improve pregnancy outcome in mice. Nature Communications 16(1):6522. DOI 10.1038/s41467-025-61572-w, https://doi.org/10.1038/s41467-025-61572-w
  14. Verleng LJ, Busselaar J, Mensink M, Schrama E, Kapsenberg H, van der Keur C, Lei X, Eikmans M, Xiao Y, de Kivit S, Borst J (2026) Defining nature, responses and drivers of regulatory- and conventional CD4(+) T cells in the human term decidua. Frontiers in Immunology 17:1865340. DOI 10.3389/fimmu.2026.1865340, https://doi.org/10.3389/fimmu.2026.1865340
  15. Gomez-Lopez N, Kareus E, Lee S (2026) Immune cellular homeostasis and its breakdown at the maternal-fetal interface. Trends in Immunology 47(3):202-211. DOI 10.1016/j.it.2025.11.006, https://doi.org/10.1016/j.it.2025.11.006
  16. Powell RM, Lissauer D, Tamblyn J, Beggs A, Cox P, Moss P, Kilby MD (2017) Decidual T cells exhibit a highly differentiated phenotype and demonstrate potential fetal specificity and a strong transcriptional response to IFN. Journal of Immunology 199(10):3406-3417. DOI 10.4049/jimmunol.1700114, https://doi.org/10.4049/jimmunol.1700114
  17. Kieffer TEC, Laskewitz A, Scherjon SA, Faas MM, Prins JR (2019) Memory T Cells in Pregnancy. Frontiers in Immunology 10:625. DOI 10.3389/fimmu.2019.00625, https://doi.org/10.3389/fimmu.2019.00625
  18. Porrett PM (2018) Biologic mechanisms and clinical consequences of pregnancy alloimmunization. American Journal of Transplantation 18(5):1059-1067. DOI 10.1111/ajt.14673, https://doi.org/10.1111/ajt.14673